Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP424656.RADvYq83DhCz75hKYnQJh90exk_UOuMGEvy_KJQ6DZ-Uw130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424656.RADvYq83DhCz75hKYnQJh90exk_UOuMGEvy_KJQ6DZ-Uw130_provenance.
• NP304968.RABPf1WiYrbGeRTSfyDe6BHyKz8i4aGBTEADePFLaM1RM130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304968.RABPf1WiYrbGeRTSfyDe6BHyKz8i4aGBTEADePFLaM1RM130_provenance.
• NP346147.RAA9OTvC8EPOLyQBj88nots7mpBcyAVYrw66jOoS4R-5E130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346147.RAA9OTvC8EPOLyQBj88nots7mpBcyAVYrw66jOoS4R-5E130_provenance.
• NP731347.RAkqWYT2aNn42XJsIIn4hk_-K5rjWcOw2mS4eTU9DGJdg130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731347.RAkqWYT2aNn42XJsIIn4hk_-K5rjWcOw2mS4eTU9DGJdg130_provenance.
• NP393910.RA5E4Ehy3Gv4u7h5Vv0xSvoipwaBGMSzwbmMZKBbS9KVA130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393910.RA5E4Ehy3Gv4u7h5Vv0xSvoipwaBGMSzwbmMZKBbS9KVA130_provenance.
• NP815211.RA1v4UA4uD-a9Q0bKRat1gKADdoLr4D48TI6LQe1W49r8130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815211.RA1v4UA4uD-a9Q0bKRat1gKADdoLr4D48TI6LQe1W49r8130_provenance.
• NP559134.RAa-kjBPC0S4W8KrYuMGNwrySDT5tcdGJtnmabor95oDo130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559134.RAa-kjBPC0S4W8KrYuMGNwrySDT5tcdGJtnmabor95oDo130_provenance.
• assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP815261.RAGMwDeUEYKlKkdjVPtEvSsJ2jG1-mKHiz2eAnLxp4aew130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815261.RAGMwDeUEYKlKkdjVPtEvSsJ2jG1-mKHiz2eAnLxp4aew130_provenance.
• NP815269.RAFeM-gRVuACN_laBoGlaMQ83ok1TAx6sOjVht4EdEPEI130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815269.RAFeM-gRVuACN_laBoGlaMQ83ok1TAx6sOjVht4EdEPEI130_provenance.
• NP559131.RAKiiSHCVxAAkzL52ZGe-x5FdO1N1nhR90QFeUSMeMOUw130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559131.RAKiiSHCVxAAkzL52ZGe-x5FdO1N1nhR90QFeUSMeMOUw130_provenance.
• NP559132.RAIyolBI4VXlmk3CYko6q7zDSz0B86_aoWo0TYB5y7Gk8130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559132.RAIyolBI4VXlmk3CYko6q7zDSz0B86_aoWo0TYB5y7Gk8130_provenance.
• NP559136.RALfCf9DfKxUcHHjLcocIca8lvNRMFkinwPYHsU09eSwA130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559136.RALfCf9DfKxUcHHjLcocIca8lvNRMFkinwPYHsU09eSwA130_provenance.
• NP815291.RAtCwIOvYSYpFsY7MMH4zY7NceQsy3oEoTGE8vu5ejTC4130_assertion description "[The highest levels of MTA1 expression were observed in diffuse B-cell lymphoma (mean staining intensity, 3.9/4), basal cell carcinomas (3.7/4), and consistently in tumors of neuroendocrine descent such as paraganglioma (3.7/4) and carcinoid tumor (3.1/4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815291.RAtCwIOvYSYpFsY7MMH4zY7NceQsy3oEoTGE8vu5ejTC4130_provenance.